AstraZeneca Pharma India Limited has submitted a regulatory disclosure to the Bombay Stock Exchange Limited and National Stock Exchange of India Limited regarding the authorization of Key Managerial Personnel for determining materiality of events and information for stock exchange disclosures.
The disclosure is made pursuant to Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and becomes effective from November 9, 2026.
Key Managerial Personnel Details
The following individuals are authorized to determine materiality of events/information:
1. Mr. Praveen Rao Akkinepally - Managing Director
Contact: Praveen.Akkinepally@astrazeneca.com
2. Mr. Atul Tandon - Chief Financial Officer
Contact: Atul.Tandon@astrazeneca.com
3. Ms. Tanya Sanish - Company Secretary
Contact: tanya.sanish@astrazeneca.com